New Key Statistics Module, Z-Score and F-Score
OTCPK:AGRX Key Ratios
Market Cap $ M | 2.63 |
Enterprise Value $ M | 2.25 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 0.04 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 19.00 |
EPS (TTM) $ | -9.74 |
Beneish M-Score | -8.19 |
10-y EBITDA Growth Rate % | 37.00 |
5-y EBITDA Growth Rate % | 61.90 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.18 |
EV-to-EBITDA | -0.19 |
PEG | -- |
Shares Outstanding M | 6.86 |
Net Margin (%) | -73.85 |
Operating Margin % | -101.50 |
Pre-tax Margin (%) | -73.85 |
Quick Ratio | 0.33 |
Current Ratio | 0.46 |
ROA % (ttm) | -117.33 |
ROE % (ttm) | -- |
ROIC % (ttm) | -372.84 |
Dividend Yield % | -- |
Altman Z-Score | -61.31 |
AGRX Number of Guru Trades
AGRX Volume of Guru Trades
Gurus Latest Trades with OTCPK:AGRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:AGRX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Agile Therapeutics Inc Insider Transactions
No Available Data
News about OTCPK:AGRX
Total 0- 1